Homocysteine, the bad thiol

Hepatology

Volumn 41, Issue 5, 2005, Pages 976-979

  Mato, José M ^a   Lu, Shelly C ^b  

^a CIC BIOGUNE   (Spain)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; THIOL;

ALCOHOL LIVER CIRRHOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL LEVEL; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; DISEASE COURSE; DNA METHYLATION; EDITORIAL; FATTY LIVER; GENOTYPE; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; LIVER CIRRHOSIS; METABOLISM; OXIDATION REDUCTION REACTION; PATHOGENESIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RNA METHYLATION;

ANIMALS; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; LIVER DISEASES; SULFHYDRYL COMPOUNDS;

EID: 17844378176     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20708     Document Type: Editorial

References (26)

1. Butz LW, du Vigneaud V. The formation of a homologue of cystine by the decomposition of methionine with sulfuric acid. J Biol Chem 1932;99:135-142.
2. Refsun H, Ueland P, Nygärd O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
3. Ji C, Kaplowitz N. Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. World J Gastro 2004;10:1699-1708.
4. Finkelstein JD. Pathways and regulation of homocysteine metabolism in mammals. Semin Thromb Hemost 2000;26:219-225.
5. Kinsell LW, Harper HA, Barton HC, Michaels GD, Weiss HA. Rate of disappearance from plasma of intravenously administered methionine in patients with liver damage. Science 1947; 106:589-954.
6. Horowitz JH, Rypins EB, Henderson JM, Heymsfield SB, Moffitt SD, Bain RP, et al. Evidence for impairment of transsulfuration pathway in cirrhosis. Gastroenterology 1981;81:668-75
7. Martín-Duce A, Ortiz P, Cabrero C, Mato JM. Adenosyl-L-methionine synthetase and phospholipids methyltransferase are inhibited in human cirrhosis. HEPATOLOGY 1988;8:65-68.
8. Lu SC. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J 1999;13:1169-1183.
9. Bostom AG, Lathrop L. Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerosis outcomes. Kidney Int 1997;52:10-20.
10. Eskes TKAB. Open or closed? A word of differences: A history of homocysteine research. Nutr Rev 1998;56:236-244.
11. Lehmann M, Gottfries CG, Regland B. Identification of cognitive impairment in the elderly: Homocysteine is an early marker. Dementia 1999;10:12-20.
12. Ji C, Kaplowitz N. Betaine decreases hyperyhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 2003;124:1488-1499.
13. Rozen R. Polymorphisms of folate and cobalamin metabolism. In: Carmel R, Jacobsen DW, eds. Homocysteine in Health and Disease. UK: Cambridge University Press, 2001;259-270.
14. Adinolfi LE, Ingrosso D, Cesaro G, Cimmino A, D'Antò, Capasso R, et al. Hyperhomocysteinemia and MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C. HEPATOLOGY 2005;41:995-1003.
15. Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 1996;93:7-9.
16. Shivapurkar N, Poirier LA. Tissue levels of S-adenosylmethionine and S-adenosylhomocysteine in rats fed methyl-deficient, amino acid-defined diets for one to five weeks. Carcinogenesis 1983;4:1051-1057.
17. Lu SC, Alvarez L, Huang ZZ, Chen LX, An W, Corrales FJ, et al. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Nat Acad Sci U S A 2001;98:5560-5565.
18. Martínez-Chantar ML, Corrales FJ, Martínez-Cruz A, García-Trevijano ER, Huang ZZ, Chen LX, et al. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J 2002;16:1292-1294.
19. Schwahn BC, Chen Z, Laryea MD, Wendel U, Lussier-Cacan S, Genest J Jr, et al. Homocysteine-betaine interactions in a murine model of 5,10- methylenetetrahydrofolate reductase deficiency. FASEB J 2003;17:512-514.
20. Upchurch GR, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr, et al. Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 1997; 272:17012-17017.
21. Werstuck GH, Lentz SR, Dayal S, Hossain GS, Sood SK, Shi YY, et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001;107:1263-1273.
22. Clarke S, Banfield K. S-Adenosylmethionine-dependent methyltransferases. In: Carmel R, Jacobsen DW, eds. Homocysteine in Health and Disease. UK: Cambridge University Press, 2001:63-78.
23. Baernstein HD. A modification of the method for determining methionine in proteins. J Biol Chem 1934;106:451-456.
24. Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J 1999;13:2277-2283.
25. Lonardo A, Adinofi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 2004;126:586-597.
26. Torres L, García-Trevijano E, Rodríguez JA, Carretero MV, Bustos M, Fernández E, et al. Induction of TIMP-1 expression in rat hepatic stellate cells and hepatocytes: a new role for homocysteine in liver fibrosis. Biochim Biophys Acta 1999;1455:12-22.